Maria Rosa Biagini
University of Florence, Azienda Ospedaliero-Universitaria Careggi
Papers
2
Total Citations
17
H-Index
2
About
Maria Rosa Biagini is a leading figure in interventional oncology, with her research focused on enhancing the precision of stereotactic body radiation therapy (SBRT) for liver malignancies. Her major contributions center on the critical, yet often overlooked, step of fiducial marker placement. Through pioneering pilot and comparative studies, Biagini systematically evaluated the therapeutic usability and tracking accuracy of different gold fiducial markers and needle gauges for robotic radiosurgery systems like CyberKnife. Her work, including a key 2016 pilot study and a 2017 comparative analysis, provides essential clinical evidence on the feasibility and safety of percutaneous ultrasound-guided marker placement. By comparing various marker types, she has directly informed best practices to improve tumor targeting and treatment outcomes. While her most cited papers have garnered foundational citations (9 and 8 respectively), their true impact lies in establishing a methodological standard for a technically demanding procedure. Biagini’s meticulous approach has made her a vital contributor to the safe and effective application of non-invasive liver cancer treatments.
Research Focus
Key Achievements
Top Papers
- 1
- 2